Organizations Filed Purposes:
To fund innovative research towards curing Huntington's disease and impacting other brain disorders.
The Hereditary Disease Foundation commemorates its 51st year by making an even greater impact toward developing novel therapeutics and cures. We have put in place strategies and new grant funding programs to maximize our effectiveness. We have been funding catalytic and paradigm-changing research since our birth - including identifying the Huntington's Disease marker in 1983 and the HD Gene in 1993, and supporting gene silencing approaches since 2002. We want to continue to make an impact by funding research that pushes the envelope.The Hereditary Disease Foundation provides funding for research that advances the discovery and development of treatments for Huntington's Disease and other brain disorders. We are passionate about funding and the Foundation intends to use the endowment funds for its scientific activities which includes providing grants to fund scientific research to further the understanding of, and to develop diagnostics and therapeutics for neurodegenerative diseases, including Huntington's Disease. The Hereditary Disease Foundation funds the most innovative, creative and paradigm-changing research possible. The data generated with HDF funding often allows researchers to get initial findings that help them apply successfully for larger, long-term funding from other funding agencies, including the National Institutes of Health. The Foundation's current focus is on:1) Modifier Studies - On DNA repair pathways, protein degradation and other modifiers of phenotype and age of onset.2) Research mechanisms of HD neurogeneration and biomarkers and therapy for HD-induced neurodegeneration.Type of funding:The Basic Research Grants Program: Supports projects contributing to identifying and understanding the fundamental defects in Huntington's Disease. Postdoctoral Fellowships: These postdoctoral fellowships are intended to cultivate interest in Huntington's Disease research by bright young scientists. Fellowships are granted to those who possess imagination, rigor, creativity and spirit to push forward toward a cure for HD and ensure that these learning can be applied to other brain diseases.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Meghan Donaldson | CEO | 30 | $110,000 |
| Travis Carey | CFO | 3 | $19,084 |
| Sandy Fox | Director | 1 | $0 |
| Robi Blumenstein | Director | 1 | $0 |
| Herbert Pardes Md | Director | 2 | $0 |
| Karen Newman | Director | 6 | $0 |
| Joan Leiman | Director | 1 | $0 |
| David Housman Phd | Director | 1 | $0 |
| Barry Evenchick | Director | 1 | $0 |
| Kelly Posner Gerstenhaber Phd | Director | 1 | $0 |
| David Gerstenhaber | Director | 1 | $0 |
| Frank Gehry | Director | 1 | $0 |
| Berta Gehry | Director | 1 | $0 |
| Anne Young Md Phd | Vice Chair | 1 | $0 |
| David Zwally | Chair | 1 | $0 |
| Bruce Donaldson | Treasurer | 1 | $0 |
| Alice Wexler Phd | Secretary | 1 | $0 |
| Nancy Wexler Phd | President | 7 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202003169349300440_public.xml